A Promising Approach to Provide Appropriate Colon Target Drug Delivery Systems of Vancomycin HCL: Pharmaceutical and Microbiological Studies

Vancomycin HCl was prepared as orally administered colon target drug delivery tablets for systemic therapy. Tablet matrices containing 10–60% of tablet weight of guar gum (F1–F6) were prepared by direct compression and subjected to in vitro release studies to explore their sustained release in the colon. Various synthetic and natural polymers were incorporated to F6 to modify the drug release rate. Different 15 matrix tablet formulations (F6–F20) were enteric coated with hydroxypropyl methyl cellulose phthalate. F6, F13 and F20 showed promising sustained release results having median dissolution time (MDT) values: 8.25, 7.97, and 7.64, respectively. Microbiological assay was performed to test the efficacy of F6, F13, and F20 to inhibit clinical Staphylococcus aureus (SA) isolates. Bactericidal activity of F6 was reached after 2, 4, and 24 hours of incubation against MSSA 18, MRSA 29, and MRSA 11 strains, respectively, while it was reached within 6–8 hours in case of F13, and F20 against all strains tested. F13 enhanced log microbial reduction by 1.74, 0.65 and 2.4 CFU/mL compared to F6 while it was 1, 2.57 and 1.57 compared to F20 against MSSA18, MRSA11 and MRSA29, respectively. Vancomycin HCl tablets displayed a promising sustained release in vitro and microbiological inhibitory action on all isolates tested.

[1]  B. A. Prasath.  Colon targeted drug delivery of propranolol hydro chloride by using different natural polymers , 2016 .

[2]  A. Fouad,et al.  Time-kill behaviour against eight bacterial species and cytotoxicity of antibacterial monomers. , 2013, Journal of dentistry.

[3]  Pradeep Kumar,et al.  Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations. , 2011, Acta poloniae pharmaceutica.

[4]  F. Saul,et al.  Molecular Basis of Vancomycin Dependence in VanA-Type Staphylococcus aureus VRSA-9 , 2010, Journal of bacteriology.

[5]  K. Pathak,et al.  Optimized prodrug approach: A means for achieving enhanced anti-inflammatory potential in experimentally induced colitis , 2009, Journal of drug targeting.

[6]  B. Luppi,et al.  Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  Taravat Ghafourian,et al.  A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling. , 2007, Journal of pharmaceutical sciences.

[8]  F. Kong,et al.  Agar Dilution Method for Detection of Inducible Clindamycin Resistance in Staphylococcus spp , 2007, Journal of Clinical Microbiology.

[9]  H. K. Tiwari,et al.  Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India , 2006, BMC infectious diseases.

[10]  Fred C Tenover,et al.  Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. , 2006, The Journal of infectious diseases.

[11]  J. Fell,et al.  In‐vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon , 2005, The Journal of pharmacy and pharmacology.

[12]  B. Luppi,et al.  Controlled release of vancomycin from freeze-dried chitosan salts coated with different fatty acids by spray-drying , 2003, Journal of microencapsulation.

[13]  L. Chan,et al.  Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[14]  N A Peppas,et al.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001, Advanced drug delivery reviews.

[15]  M Alpsten,et al.  In vitro and in vivo erosion of two different hydrophilic gel matrix tablets. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  A. Almeida,et al.  Hydroxypropyl methylcellulose phthalate beads containing a model non-steroid anti-inflammatory drug , 1998 .

[17]  H. Chambers.  Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications , 1997, Clinical microbiology reviews.

[18]  G. Macfarlane,et al.  Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture. , 1990, The Journal of applied bacteriology.

[19]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[20]  Jyothi,et al.  Formulation and evaluation of gum based matrix tablets of Lamivudine , 2011 .

[21]  H. Jain,et al.  Colon-targeted quercetin delivery using natural polymer to enhance its bioavailability , 2011, Pharmacognosy research.

[22]  Y. Rao,et al.  Modulating the Release Behavior and Kinetic Evaluation of Diclofenac Sodium from Natural Polymers , 2010 .

[23]  M. Varma,et al.  Design development and evaluation of extended release tablets of Alfuzosin hydrochloride , 2010 .

[24]  B. Luppi,et al.  Pectin-based microspheres for colon-specific delivery of vancomycin. , 2009, The Journal of pharmacy and pharmacology.

[25]  B. Luppi,et al.  Chitosan salts coated with stearic acid as colon-specific delivery systems for vancomycin. , 2008, Drug delivery.

[26]  B. Tashtoush,et al.  Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium , 2008, AAPS PharmSciTech.

[27]  Patrice Courvalin,et al.  Vancomycin resistance in gram-positive cocci. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  M. K. Chourasia,et al.  Pharmaceutical approaches to colon targeted drug delivery systems. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[29]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[30]  L. Lou.  Novel drug delivery systems , 1999, Current review of pain.

[31]  G. Simon,et al.  Intestinal flora in health and disease. , 1984, Gastroenterology.

[32]  S. A. Barker.  Industrial Gums , 1960, Nature.